At the sixth annual Russian Pharma Awards 2017, Polyoxidonium, a Russian combination product that is an immunomodulator, detoxifier, and antioxidant, took the prize for «Product of choice for treating and preventing acute viral respiratory infection in children».

MMC Norilsk Nickel has launched hot commissioning operations at Bystrinsky GOK (Bystrinsky mining and processing plant).

Boehringer Ingelheim has concluded phase one of their localization effort aimed at manufacturing their innovative thrombolytic medicines in Russia: the first batches of Metalyse (tenectaplase) for acute heart attack treatment were produced at NPO Petrovax Pharm facilities.

MMC Norilsk Nickel was rated 63 on the American magazine Forbes’ list of the world’s 100 most innovative companies.